Literature DB >> 9640617

Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study.

P Butthep1, A Bunyaratvej, Y Funahara, H Kitaguchi, S Fucharoen, S Sato, N Bhamarapravati.   

Abstract

Activation of vascular endothelium is considered as an important facet of inflammation, thrombosis, and vasculitis. Activated endothelial cells express a number of immunologically relevant surface markers which are not detected in dormant condition. These surface markers on endothelial cell may involve in adhesion reaction and migration of blood cell components. We demonstrated increased level of the soluble adhesion molecules in circulating blood of both alpha- and beta-thalassemic patients. These adhesion molecules are theoretically known to be released from endothelial cells. The adhesion molecules included soluble Intercellular Adhesion Molecule-1 (sICAM-1), soluble E-Selectin (ELAM-1), soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1), and von Willebrand Factor (vWF). The levels of these adhesion molecules were measured in serum from 32 thalassemic patients and 10 control healthy subjects. As compared to normal, increased sICAM-1 was found in beta-thal/HbE patients with non-splenectomy; BE-NS (p = 0.002), increased ELAM-1 in beta-thal/HbE patients with splenectomy; BE-S (p = 0.01) and HbH with Hb Constant Spring; HbH/CS (p = 0.001), and increased sVCAM-1 in BE-NS; (p = < 0.0001) and BE-S (p = 0.002). Significant increase in von Willebrand Factor (vWF), a marker for endothelial cell, was shown in BE-S (p = 0.04) as compared to normal. Adhesion molecules were also markedly demonstrated in the supernatant of in vitro culture of human vascular endothelial cell in the presence of 30% thalassemic serum, and these adhesion molecules were also detected on the surface of the cells by using the technic of laser scanning confocal microscope and direct immunofluorescence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9640617

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  9 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Thrombin Activable Fibrinolysis Inhibitor in Beta Thalassemia.

Authors:  Aruna Chhikara; Sunita Sharma; Jagdish Chandra; Anita Nangia
Journal:  Indian J Pediatr       Date:  2016-08-03       Impact factor: 1.967

3.  Absence of JAK2V617F mutation in patients with beta-thalassemia major and thrombocytosis due to splenectomy.

Authors:  E Vlachaki; A Kalogeridis; N Neokleous; V Perifanis; F Klonizakis; E Ioannidou; I Klonizakis
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

4.  A case of alpha-thalassemia-2 associated with pulmonary infarction.

Authors:  Seiji Hayashi; Hiroto Matsuoka; Teruo Harano; Keiko Harano; Hiroshi Nakahara; Isao Tachibana; Hiroshi Kida; Tomio Kawasaki; Shingo Kyotani; Yoshihiro Oka; Mitsunori Sakatani; Ichiro Kawase
Journal:  Lung       Date:  2006 Jul-Aug       Impact factor: 2.584

Review 5.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

6.  Vascular dysfunction in a murine model of severe hemolysis.

Authors:  Anne C Frei; YiHe Guo; Deron W Jones; Kirkwood A Pritchard; Karen A Fagan; Neil Hogg; Nancy J Wandersee
Journal:  Blood       Date:  2008-05-13       Impact factor: 22.113

7.  Coagulopathy in Beta-thalassemia: current understanding and future perspectives.

Authors:  M Domenica Cappellini; Khaled M Musallam; Alessia Marcon; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-29       Impact factor: 2.576

8.  Thalassemia and venous thromboembolism.

Authors:  Julien Succar; Khaled M Musallam; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-25       Impact factor: 2.576

9.  Papillary Fibroelastoma as a Cause of Cardiogenic Embolic Stroke in a β-Thalassemia Patient: Case Report and Literature Review.

Authors:  Re-I Chin; John J Monda; Maulik Sheth; William Ogle; Gloria Merenda; Debapriya De
Journal:  Case Rep Cardiol       Date:  2017-03-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.